SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-038441
Filing Date
2024-03-25
Accepted
2024-03-25 16:05:01
Documents
21
Period of Report
2024-03-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FROM 8-K tm249625d2_8k.htm   iXBRL 8-K 37419
2 EXHIBIT 4.1 tm249625d2_ex4-1.htm EX-4.1 83295
3 EXHIBIT 4.2 tm249625d2_ex4-2.htm EX-4.2 89133
4 EXHIBIT 5.1 tm249625d2_ex5-1.htm EX-5.1 22321
5 EXHIBIT 10.1 tm249625d2_ex10-1.htm EX-10.1 184055
9 GRAPHIC image_004.jpg GRAPHIC 11590
10 GRAPHIC tm249625d2_ex4-1img002.jpg GRAPHIC 1910
11 GRAPHIC tm249625d2_ex4-2img001.jpg GRAPHIC 3854
12 GRAPHIC tm249625d2_ex5-1img002.jpg GRAPHIC 5454
  Complete submission text file 0001104659-24-038441.txt   726690

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA btai-20240325.xsd EX-101.SCH 3048
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE btai-20240325_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btai-20240325_pre.xml EX-101.PRE 22381
24 EXTRACTED XBRL INSTANCE DOCUMENT tm249625d2_8k_htm.xml XML 3496
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 24779192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)